Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol TCI in Hemodialysis Patients Undergoing AV Shunt Surgery
NCT03311581Phase 1Completed
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Sep 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of propofol in end stage renal disease (ESRD) (2 arms), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Primary endpoint: Change in blood pressure at 4 hours. Started Sep 2017; status: completed.
02
Drugs
propofol
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT03311581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03311581.